Poland will look to defy Portugal and Hungary are aiming high in the penultimate round of league phase fixtures in the ...

Shares of Immutep (NASDAQ:IMMP) climbed 11% Thursday after the Australian company reported positive data from two clinical trials of its drug candidate eftilagimod alpha, or efti. Immutep (IMMP) said ...

Seeking to bring renovations, improvements and new facilities to seven ACPL branches, Phase 1 of the master plan included the ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

Old Man Winter is knocking on the door - so we're asking the question: How much snow can we expect this winter in the D.C.

Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic ...

The Centre on Thursday launched the Partnerships for Accelerated Innovation and Research (PAIR) programme, designed to ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Phase II Expansion: * Groundbreaking ceremony for the expansion ... Recorded total income of Rs. 149.1 cr and PBT of Rs. 34.2 ...